New York Attorney General Letitia James has sued 3M, DuPont, Chemours, Corteva and related entities over PFAS, seeking cleanup funding, consumer warnings, damages and civil penalties.
New York Attorney General Letitia James has sued 3M, DuPont de Nemours, The Chemours Company, Corteva and related entities in Albany state court over PFAS, the synthetic compounds often called forever chemicals.
The complaint alleges the companies sold PFAS-containing products while concealing or failing to warn about health and environmental risks. New York is asking the court to make the companies help fund environmental cleanup, warn consumers about PFAS dangers and pay damages and penalties.
James said in a statement reported by the Associated Press that major chemical companies knowingly sold toxic products that threatened New Yorkers' health and polluted the environment for decades.
What New York alleges
PFAS are persistent synthetic chemicals used in products such as cosmetics, non-stick cookware and firefighting foam. They have become a major target for state attorneys general, local governments and other plaintiffs seeking cleanup money and warning requirements from manufacturers.
In this case, New York says the companies put PFAS products into commerce while withholding or downplaying what they knew about the risks. The lawsuit frames the issue as both an environmental contamination case and a consumer-protection case.
The state is also seeking a court order that would require the companies to warn consumers about PFAS in their products. That could expand the legal and practical obligations tied to selling these chemicals in New York.
Why the case matters
According to the Wall Street Journal, New York is also seeking court recognition of PFAS dangers, environmental remediation, compensatory damages, civil penalties and disgorgement. Those remedies would go beyond reimbursement and put direct financial pressure on the defendants.
The cleanup request matters because PFAS contamination can be expensive and long-lasting to address. The case could affect how future remediation is paid for if the state succeeds in shifting more of that burden to manufacturers.
The warning request is equally significant. If a court orders consumer warnings, it could affect how PFAS-containing products are sold and labeled in New York and potentially influence similar actions in other states.
Alleged corporate knowledge
WSJ reported that James alleges the companies knew about PFAS toxicity as early as the 1970s and 1980s. That is the state's allegation, not a finding by a court.
The long timeline is important because it suggests New York's case is built not only on the presence of PFAS in products, but also on the claim that the companies understood the risks earlier than they disclosed them.
That theory fits a broader pattern in PFAS litigation, where plaintiffs often argue that manufacturers continued selling the chemicals while the hazards were being identified internally or in the scientific literature.
Litigation backdrop
The filing lands amid a wider wave of PFAS cases around the country. AP reported that it comes after a 2025 New Jersey settlement involving DuPont, Chemours and Corteva over PFAS-related environmental claims.
WSJ also reported that Chemours recently reached a $450 million federal settlement over PFAS contamination in West Virginia, North Carolina and New Jersey. That settlement adds to the mounting financial exposure for companies in the sector.
Taken together, those cases show how PFAS litigation has become a recurring legal risk for the same group of manufacturers, with states increasingly pursuing cleanup costs, warnings and broader public remedies.
What happens next
AP reported that the companies did not immediately respond to requests for comment, so the first public record does not yet include detailed defendant responses to the allegations.
The complaint text should clarify which PFAS products and which New York contamination sites are central to the case. It should also show whether the state is alleging a single industry-wide scheme or distinct conduct by each defendant.
For now, the case is a fresh escalation in state-level PFAS enforcement. The main immediate questions are whether any defendant files a response, whether New York seeks interim relief and how aggressively the state pursues cleanup and warning orders.
The lawsuit is being watched as a potential precedent for how far New York, and other states, may go in trying to make chemical manufacturers pay for the environmental and public-health costs linked to PFAS.
Revision note
Initial automated publication with expanded verified context.